Literature DB >> 12574072

Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals.

Craig R Weinert1, Cynthia R Gross, William A Marinelli.   

Abstract

Reducing tidal volumes administered to patients with acute lung injury is the only intervention reported to decrease mortality resulting from this life-threatening condition. Whereas many medical advances are slowly brought into practice, clinicians in teaching hospitals are often assumed to be early adopters of new medical advances. Our objective was to examine trends in the ventilatory prescription for 398 patients with acute lung injury treated in three teaching hospitals from 1994 to 2001. There was no change in tidal volumes until mid to late 1998, when volumes started to slowly decline at the rate of 48.0 (95% confidence interval, 21.0 to 74.4) ml/year. In the 2 years after the results were released from a large trial that demonstrated the superiority of 6 ml/kg tidal volume therapy over 12 ml/kg, clinicians prescribed tidal volumes of 651 +/- 128 ml or 10.1 +/- 1.9 ml/kg. Tidal volumes after intubation were minimally reduced over the subsequent 2 days of mechanical ventilation (mean reduction, 33 ml). Hospital category, male sex, and disease onset before May 1999 were associated with higher volumes whereas lung injury severity was inversely associated. We conclude that clinicians practicing at these teaching hospitals have not rapidly adopted low tidal volume ventilation that may reduce mortality.

Entities:  

Mesh:

Year:  2003        PMID: 12574072     DOI: 10.1164/rccm.200205-478OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  60 in total

Review 1.  Permissive hypercapnia--role in protective lung ventilatory strategies.

Authors:  John G Laffey; Donall O'Croinin; Paul McLoughlin; Brian P Kavanagh
Journal:  Intensive Care Med       Date:  2004-01-14       Impact factor: 17.440

2.  Medication error reporting systems: a survey of canadian intensive care units.

Authors:  Kimberley Louie; Amanda Wilmer; Hubert Wong; Maja Grubisic; Najib Ayas; Peter Dodek
Journal:  Can J Hosp Pharm       Date:  2010-01

Review 3.  Prompting physicians to address a daily checklist for antibiotics: do we need a co-pilot in the ICU?

Authors:  Curtis H Weiss; Richard G Wunderink
Journal:  Curr Opin Crit Care       Date:  2013-10       Impact factor: 3.687

4.  Why are physicians so skeptical about positive randomized controlled clinical trials in critical care medicine?

Authors:  Jesús Villar; Lina Pérez-Méndez; Armando Aguirre-Jaime; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2004-11-23       Impact factor: 17.440

5.  Controversial choice of a control intervention in a trial of ventilator therapy in ARDS: standard of care arguments in a randomised controlled trial.

Authors:  H Mann
Journal:  J Med Ethics       Date:  2005-09       Impact factor: 2.903

6.  Tight glycaemic control: a survey of intensive care practice in large English hospitals.

Authors:  Iain Mackenzie; Susan Ingle; Suhail Zaidi; Simon Buczaski
Journal:  Intensive Care Med       Date:  2005-06-14       Impact factor: 17.440

7.  The European Society of Intensive Care Medicine (ESICM) and the Surviving Sepsis Campaign (SSC).

Authors:  V Marco Ranieri; Rui P Moreno; Andy Rhodes
Journal:  Intensive Care Med       Date:  2007-02-16       Impact factor: 17.440

8.  Increased use of noninvasive ventilation in French intensive care units.

Authors:  Alexandre Demoule; Emmanuelle Girou; Jean-Christophe Richard; Solenne Taillé; Laurent Brochard
Journal:  Intensive Care Med       Date:  2006-06-24       Impact factor: 17.440

9.  Mechanical ventilation and air leaks after lung biopsy for acute respiratory distress syndrome.

Authors:  Michael H Cho; Atul Malhotra; Dean M Donahue; John C Wain; R Scott Harris; Dimitri Karmpaliotis; Sanjay R Patel
Journal:  Ann Thorac Surg       Date:  2006-07       Impact factor: 4.330

10.  Ventilatory strategies in patients with sepsis and respiratory failure.

Authors:  Dean R Hess; B Taylor Thompson
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.